alexa Interview | Leonard AmaralnbspBiochemistry and Pharmaco
ISSN: 2167-0501

Biochemistry & Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
Leonard Amaral
Leonard Amaral

Leonard Amaral
Institute of Hygiene & Tropical Medicine
Portugal
Read Interview session with Leonard Amaral

 
Biography

Leonard Amaral, M.D., PhD, Emeritus Professor, Universidade Nova de Lisboa and Distinguished Invited Scientist Fellow of the Fundacao de Ciencias e Tecnologia de Portugal.
Areas of current main contributions:
Development of therapy by which the resistance of MDR/XDR Mtb is by-passed and the non-killing macrophage is transformed into a killer of MDR/XDR Mtb.
Therapy of MDR/XDR TB with an inexpensive drug that is beyond patent protection, has no serious toxicity and has been now shown to cure XDR TB.
Development of new methods for the characterisation, evaluation and assessment of efflux pumps that render bacteria and cancer cells resistant to therapy.
Demonstration of biophysical/biochem mechanisms by which efflux pumps render bacteria multi-drug resistant.
Development of new theories for therapy of cancer based upon the 2nd law of thermodynamics.

Publication Record; over 200 scientific articles in Peer Review International Journals
Publications in Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods for Clinical Laboratories
Research Activity:
Development of drugs that are active (kill) against intracellular MDRTB and XDRTB.
Development of methods that assess and evaluate efflux pump activity of MDR bacteria.
Mechanisms by which efflux pumps are genetically controlled and regulated.
Development of agents that inhibit and or regulate efflux pumps.
Control of permeability of MDR bacteria to antibiotics.
Development of drugs that inhibit ABC transporters of mdr cancer cells.
Collaboration with 38 European Scientists from 33 countries via the Cost Action Programmes of the Eur Comm/Eur Sci FND-Cost Action B16 and BM0701 (ATENS).
Research supported by the Foundation of Science and Technology of Portugal
Workshops supported by the European Science Foundation
Interactive and cooperative projects supported by treaties between Portugal and participating EU countries
Leader in clinical trials for therapy of MDR/XDR TB infections.
 

 
Research Interest

Development of drugs that are active (kill) against intracellular MDRTB and XDRTB.
Development of methods that assess and evaluate efflux pump activity of MDR bacteria.
Mechanisms by which efflux pumps are genetically controlled and regulated.
Development of agents that inhibit and or regulate efflux pumps.
Control of permeability of MDR bacteria to antibiotics.
Development of drugs that inhibit ABC transporters of mdr cancer cells.
 

Interview
1. How many years have you been practicing and/or performing research?
49 yrs.

2. What is the research topic you are working on now?
MDR Cancer.

3. What makes an article top quality?
Importance and clinical relevance.

4. What are the qualities you look for in an article?
Importance and clinical relevance

5. Do you have any research funding (NIH or other national funding) now?
No

6. When did you become an editor of OMICS Journal?
2010

7. What is your greatest career accomplishment?
Yet to come

8. How does the research published percolate through to practitioners?
By word of mouth.

9. What is the purpose of serving as an editor?
Responsibility to biomed science.

10. Do you have any patents?
Yes

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Yes

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
Yes

13. Do you have any trouble with OMICS Journals in the past?
No

14. Would you recommend OMICS to your friends or colleagues?
Yes

15. How do you differentiate Biochemistry & Pharmacology: Open Access with other journals in the field?
Very good support during review/editing process.
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords